NCT05825274View on ClinicalTrials.gov

TDCs to Treat Drug-resistant Epilepsy

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

October 1, 2017

Study Completion Date

December 28, 2017

Conditions
Other Forms of Epilepsy, Treatment Resistant
Interventions
DEVICE

Cathodal tDCS

We do 2 sessions per week of 35 minutes with cathodal electrodes over epileptic focus

Trial Locations (1)

L1 0AH

New Remedies Ltd, Liverpool

All Listed Sponsors
lead

Spanish Foundation for Neurometrics Development

OTHER

NCT05825274 - TDCs to Treat Drug-resistant Epilepsy | Biotech Hunter | Biotech Hunter